192 related articles for article (PubMed ID: 17340994)
1. [MIC and MBC of quinupristin/dalfopristin of erythromycin-resistant MRSA strains isolated from clinical specimens].
Młynarczyk G; Młynarczyk A; Szymanek K; Bilewska A; Pupek J; Luczak M
Med Dosw Mikrobiol; 2006; 58(3):199-205. PubMed ID: 17340994
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VK; Rohani MY; Kamel AG
Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
[TBL] [Abstract][Full Text] [Related]
3. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
[TBL] [Abstract][Full Text] [Related]
4. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type.
Clarebout G; Nativelle E; Bozdogan B; Villers C; Leclercq R
Int J Antimicrob Agents; 2004 Nov; 24(5):444-9. PubMed ID: 15519475
[TBL] [Abstract][Full Text] [Related]
6. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey.
Azap OK; Arslan H; Timurkaynak F; Yapar G; Oruç E; Gagir U
Clin Microbiol Infect; 2005 Jul; 11(7):582-4. PubMed ID: 15966979
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
10. [Occurrence of macrolide-lincosamide-streptogramin B resistant isolates of Staphylococcus aureus in clinical specimens in 2003-2004].
Kaczmarek A; Budzyńska A; Gospodarek E
Med Dosw Mikrobiol; 2006; 58(2):103-11. PubMed ID: 17133903
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
Jørgen B; Merckoll P; Melby KK
Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
Neela V; Sasikumar M; Ghaznavi GR; Zamberi S; Mariana S
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates.
Millán L; Cerdá P; Rubio MC; Goñi P; Canales M; Capilla S; Oca M; Gómez-Lus R
J Chemother; 2004 Jun; 16(3):230-7. PubMed ID: 15330317
[TBL] [Abstract][Full Text] [Related]
14. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus.
Marr JK; Lim AT; Yamamoto LG
Hawaii Med J; 2005 Jan; 64(1):6-8. PubMed ID: 15751751
[TBL] [Abstract][Full Text] [Related]
15. A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.
Low DE; Nadler HL
J Antimicrob Chemother; 1997 May; 39 Suppl A():53-8. PubMed ID: 9511063
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility to selected chemotherapeutics of Staphylococcus aureus strains resistant to methycyline isolated from clinical materials in the years 1991-1992 and 1997].
Kochman M; Fordymacki P; Lawrynowicz-Paciorek M; Kałuzewski S; Mészáros J; Połowniak-Pracka H; Ochman E; Sztandar-Sztanderska M
Med Dosw Mikrobiol; 1999; 51(3-4):187-98. PubMed ID: 10803247
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
[TBL] [Abstract][Full Text] [Related]
18. [Study on the resistance of methicillin-resistant staphylococcus aureus to iodophor and chlorhexidine].
Zhang YH; Liu XY; Zhu LL; Yu YZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):248-50. PubMed ID: 15200941
[TBL] [Abstract][Full Text] [Related]
19. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
Saravolatz LD; Pawlak J; Johnson LB
J Antimicrob Chemother; 2007 Aug; 60(2):406-9. PubMed ID: 17586562
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
